Product Images Camrese Lo

This appears to be a table or chart with information on various studies related to the use of combined oral contraceptives (COC). The studies compare women who have ever used COC to those who have never used COC or to those who are currently using COC. The information includes estimates of effect, such as odds ratios (OR), relative risks (RR), and hazard ratios (HR). However, without further context or a clear indication of what the numbers and symbols mean, it is difficult to provide a more detailed description.*

This is a chart showing different methods of birth control and their effectiveness in preventing pregnancy. The first section shows a range of 0-1 pregnancy per 100 women in one year and the second section shows a range of 10-20 and 85 or more pregnancies per 100 women in one year. The chart lists various methods including implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal rings with hormones, condoms, diaphragm, no sex during the most fertile days of the monthly cycle, spermicide, withdrawal, and no birth control.*

This appears to be a schedule of days of the week divided into two sections with medication names and strengths listed below them. The medications listed are Camrese Lo, which contains levonorgestrel and ethinyl estradiol, and estadiol tablets of 0.01mg strength. However, the text does not provide any context or additional information.*

This text appears to be a product description for a medication called Camrese Lo, which consists of levonorgestrel/ethinyl estradiol tablets in two different strengths. The medication is intended for extended-cycle use, and is dispensed in two tablet dispensers containing a total of 91 tablets each. The text also includes a product code (NDC 0033.6148.52) and the prescription-only designation "Rxonly".*

This text seems to be a mix of different information related to medication packaging and coding. There is a mention of Extended-Cycle Tablet Dispensers with a quantity of 91 tablets, and the medication being camrese Lo which contains levonorgestrel/ethinyl estradiol with a concentration of 0.01mg/0.02mg. The text also includes some codes and a Selaization Coding Area; however, it is difficult to extract any further meaningful information from it.*